SCHEMBL4603052

SCHEMBL4603052

Cc1cncc(-c2nc(CCNCC(=O)N3CCCC3)c[nH]2)c1

nearest known ligand 0.38

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
DGAT2 Q96PD7 1/20 0.38
CYP2D6 P10635 3/20 0.38
PRMT3 O60678 2/20 0.36
DPP4 P27487 1/20 0.35
ADORA2B P29275 1/20 0.35
CYP11B2 P19099 1/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
NPC1 O15118 1/20 0.34
TP53 P04637 1/20 0.34
HPGD P15428 1/20 0.34
RAB9A P51151 1/20 0.34
HSD17B10 Q99714 1/20 0.34
DHODH Q02127 1/20 0.34
GRIN2B Q13224 2/20 0.33
LRRK2 Q5S007 1/20 0.33
SPR P35270 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4606166 0.80 CYP2D6 (0.40) CYP2D6DPP4SMN1; SMN2NPC1HPGD
SCHEMBL4605631 0.79 PRMT3 (0.43) CYP2D6PRMT3DPP4
SCHEMBL4603048 0.68 KMT2A (0.42) CYP2D6PRMT3HPGD
SCHEMBL4605625 0.67 PRMT3 (0.39) CYP2D6PRMT3DPP4SMN1; SMN2SPR
SCHEMBL22180974 0.63 TDO2 (0.44) CYP11B2LRRK2
SCHEMBL4604399 0.63 DPP4 (0.67) DPP4
SCHEMBL23778692 0.62 GABRA2 (0.50) CYP2D6SMN1; SMN2NPC1HPGDRAB9A
SCHEMBL17144250 0.62 CYP2D6 (0.46) CYP2D6PRMT3DPP4SMN1; SMN2NPC1
SCHEMBL4606161 0.61 ALDH1A1 (0.41) CYP2D6DPP4SMN1; SMN2NPC1TP53
SCHEMBL11991751 0.60 HPGD (0.56) CYP11B2SMN1; SMN2NPC1HPGDRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1917001-A2 PHARMACEUTICAL COMPOSITION COMPRISING A DPP-IV INHIBITOR F.HOFFMANN-LA ROCHE AG (CH) 2008-05-07 EP disclosed
WO-2007017423-A2 PHARMACEUTICAL COMPOSITION COMPRISING A DPP-IV INHIBITOR F. HOFFMANN-LA ROCHE AG (CH) 2007-02-15 WO disclosed